Myasthenia gravis constitutes chronic autoimmune disease that primarily targets the neuromuscular junction. This junction enables the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system mistakenly attacks these receptors, resulting weakness and fatigue in the motor units. The symptoms of my